Romania – Pharmaceutical products – Produse farmaceutice - Medicamente incluse în diferite programe naționale
Opportunity Score
Confidence: 70%
Complexity: high
31 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation
AI Analysis Summary
This is a public tender by Spitalul Judetean de Urgenta Miercurea Ciuc (Romania) for pharmaceutical products under various national health programs. It is an open procedure framework agreement with 18 lots, covering medicines for oncology, diabetes, and rare diseases. The total estimated value is 38,373,035.04 RON over 36 months. Award is based on lowest price. Submission deadline is 2026-07-16T12:00:00.000Z. Only Romanian language is accepted. Electronic submission via SEAP is required.
Strengths
Documents available
Open procedure
31 days left
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
- Framework agreement with a duration of 36 months.
- Electronic submission required via SEAP platform.
- Submission language: Romanian only.
Award Criteria
Pretul ofertei
Pretul cel mai scazut este singurul criteriu
| Criterion | Type |
|---|---|
Pretul ofertei Pretul cel mai scazut este singurul criteriu | Price |
Buyer
Name
Spitalul Judetean de Urgenta Miercurea Ciuc
Location
Miercurea-Ciuc, ROU
Website
Buyer profile
Identifier
4245305
Lots (18)
Supply of atezolizumab 1200mg concentrate for solution for infusion.
Pharmaceutical product lot 2 (description not provided).
Pharmaceutical product lot 3 (description not provided).
Procurement Details
Publication
09 Jun 2026
Deadline
16 Jul 2026, 12:00
Procedure
open
Contract
supplies
Duration
36 MONTH
Language
RON
Publication #
398113-2026
Classification
Performance: Romania
Documents (2)
Opportunity Score
Confidence: 70%
Complexity: high
31 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation